Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855837/0/en/Verrica-Pharmaceuticals-Announces-Presentation-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/26/2852256/0/en/Verrica-Pharmaceuticals-Announces-that-YCANTH-Receives-New-Chemical-Entity-Status-and-Orange-Book-Listing-from-the-FDA.html
https://www.globenewswire.com//news-release/2024/02/29/2837864/0/en/Verrica-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/27/2835891/0/en/Verrica-Pharmaceuticals-Announces-Participation-in-the-TD-Cowen-44th-Annual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2833579/0/en/Verrica-Pharmaceuticals-to-Provide-a-Corporate-Update-and-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-29-2024.html
https://www.globenewswire.com//news-release/2024/02/05/2823427/0/en/Verrica-Pharmaceuticals-Files-Lawsuit-Against-Canadian-Drug-Manufacturer-for-False-Advertising-and-Unfair-Competition.html
https://www.globenewswire.com/news-release/2024/01/29/2818804/0/en/Verrica-Pharmaceuticals-Receives-Permanent-J-Code-J7354-for-YCANTH-from-Centers-for-Medicare-and-Medicaid-Services.html
https://www.globenewswire.com//news-release/2024/01/05/2804581/0/en/Verrica-Pharmaceuticals-Announces-Last-Patient-Dosed-in-Part-2-of-Phase-2-Study-of-VP-315-a-Potential-First-in-Class-Oncolytic-Peptide-Based-Immunotherapy-for-the-Treatment-of-Basa.html
https://www.globenewswire.com//news-release/2024/01/04/2803868/0/en/Verrica-Pharmaceuticals-Announces-Receipt-of-Minutes-from-Type-C-Meeting-with-FDA-Regarding-Clinical-Development-of-YCANTH-for-the-Treatment-of-Common-Warts.html
https://www.globenewswire.com//news-release/2024/01/03/2803196/0/en/Verrica-Pharmaceuticals-Announces-Specialty-Pharmacy-Partnership-Agreement-with-Walgreens-to-Distribute-YCANTH.html